Natixis Baxter International Inc Transaction History

Natixis

$17.4 Billion
Q2 2024

A detailed history of Natixis transactions in Baxter International Inc stock. As of the latest transaction made, Natixis holds 46,733 shares of BAX stock, worth $1.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

46,733

Previous 466,538 89.98%

Holding current value

$1.84 Million

Previous $19.9 Million 92.16%

% of portfolio

0.01%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$32.87 - $43.55 $13.8 Million - $18.3 Million	-419,805 Reduced 89.98%	46,733 $1.56 Million
Q1 2024 May 13, 2024	BUY	$37.88 - $43.77 $13.2 Million - $15.2 Million	348,361 Added 294.78%	466,538 $19.9 Million
Q4 2023 Feb 13, 2024	SELL	$31.71 - $38.95 $8.74 Million - $10.7 Million	-275,603 Reduced 69.99%	118,177 $4.57 Million
Q3 2023 Nov 14, 2023	BUY	$37.32 - $49.29 $13.4 Million - $17.7 Million	358,837 Added 1026.92%	393,780 $14.9 Million
Q2 2023 Aug 11, 2023	SELL	$39.98 - $47.68 $1.41 Million - $1.68 Million	-35,162 Reduced 50.16%	34,943 $1.59 Million
Q1 2023 May 12, 2023	SELL	$37.58 - $52.57 $9.22 Million - $12.9 Million	-245,308 Reduced 77.77%	70,105 $2.84 Million
Q4 2022 Feb 24, 2023	BUY	$49.7 - $57.71 $6.71 Million - $7.79 Million	134,944 Added 74.77%	315,413 $16.1 Million
Q4 2022 Feb 13, 2023	SELL	$49.7 - $57.71 $5.74 Million - $6.67 Million	-115,564 Reduced 39.04%	180,469 $9.2 Million
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $9.34 Million - $11.6 Million	173,434 Added 141.46%	296,033 $15.9 Million
Q2 2022 Aug 12, 2022	SELL	$63.83 - $80.0 $6.57 Million - $8.24 Million	-102,948 Reduced 45.64%	122,599 $7.88 Million
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $14.9 Million - $17.4 Million	194,319 Added 622.26%	225,547 $17.5 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $14.6 Million - $17.1 Million	-196,136 Reduced 86.27%	31,228 $2.68 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $3 Million - $3.4 Million	40,668 Added 21.78%	227,364 $18.3 Million
Q2 2021 Aug 13, 2021	SELL	$80.5 - $88.01 $73.7 Million - $80.6 Million	-915,383 Reduced 83.06%	186,696 $15 Million
Q1 2021 May 14, 2021	BUY	$76.38 - $86.03 $56.2 Million - $63.3 Million	735,916 Added 200.98%	1,102,079 $92.9 Million
Q4 2020 Feb 12, 2021	BUY	$75.39 - $82.36 $27.6 Million - $30.2 Million	366,163 New	366,163 $29.4 Million
Q3 2020 Nov 12, 2020	SELL	$78.33 - $90.73 $6.26 Million - $7.25 Million	-79,944 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$78.66 - $94.14 $42.7 Million - $51.1 Million	-542,464 Reduced 87.16%	79,944 $6.88 Million
Q1 2020 May 14, 2020	BUY	$71.57 - $93.3 $44.5 Million - $58.1 Million	622,408 New	622,408 $50.5 Million
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $22 Million - $25.4 Million	-287,299 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$81.4 - $89.78 $23.4 Million - $25.8 Million	287,299 New	287,299 $25.1 Million
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $56 Million - $62.8 Million	-762,058 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$64.48 - $81.31 $49.1 Million - $62 Million	762,058 New	762,058 $62 Million
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $50.7 Million - $55.7 Million	-716,411 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$63.43 - $75.41 $17.5 Million - $20.8 Million	275,452 Added 62.47%	716,411 $52.9 Million
Q1 2018 May 15, 2018	BUY	$62.56 - $72.26 $27.6 Million - $31.9 Million	440,959 New	440,959 $28.7 Million
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $32.4 Million - $34.9 Million	-527,641 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $31.4 Million - $34.1 Million	527,641	527,641 $33.1 Million

Others Institutions Holding BAX

# of Institutions

981

Shares Held

446M

Call Options Held

2.22M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account